Form 4 for VRTX Vertex Pharmaceuticals
Accepted 2022-08-10 00:00:00 ET · period of report 2022-08-09 · accession 0000899243-22-028244 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2022-08-10 | 2022-08-09 | VRTX | Arbuckle Stuart A | EVP, COO | S - Sale+OE | $300.67 | -5,690 | 61.9K | -8% | -$1.71M |
| D | 2022-08-10 | 2022-08-09 | VRTX | Arbuckle Stuart A | EVP, COO | M - OptEx | $155.57 | +1,926 | 66.7K | +3% | +$299.6K |
| D | 2022-08-10 | 2022-08-09 | VRTX | Arbuckle Stuart A | EVP, COO | M - OptEx | $0.00 | -1,926 | 6,635 | -22% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-08-09 | S | D | 900 | $301.42 | 60,996 | D | — | — | (F2) Mr. Arbuckle undertakes to provide (upon request by the SEC staff, the Issuer or a security holder of the Issuer) full information regarding the number of shares sold at each separate price. (F4) Open market sales reported on this line occurred at a weighted average price of $301.42 (range $301.13 to $301.61). |
| 2 | Common | Common Stock | 2022-08-09 | M | A | 1,926 | $155.57 | 66,686 | D | — | — | |
| 3 | Common | Common Stock | 2022-08-09 | S | D | 4,790 | $300.53 | 61,896 | D | — | — | (F2) Mr. Arbuckle undertakes to provide (upon request by the SEC staff, the Issuer or a security holder of the Issuer) full information regarding the number of shares sold at each separate price. (F3) Open market sales reported on this line occurred at a weighted average price of $300.53 (range $300.00 to $300.84). |
| 4 | Derivative | Stock Option (Right to Buy) | 2022-08-09 | M | D | 1,926 | $0.00 | 6,635 | D | $155.57 · — to 2028-02-05 | 1,926 Common Stock | (F5) Fully vested. |